Register entry
Daewoong Pharmaceutical Co., Ltd.
- Registered sites
- 4
- Drug products
- 1
- Live patents
- 0
- Countries
- 2
- Base
- South Korea
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufactureLabellingFinished drug manufacturePackaging
Sites
Facilities
4| Site | Location | Operations | FEI |
|---|---|---|---|
| DAEWOONG PHARMACEUTICAL (INDIA) PRIVATE LIMITED | HyderabadIndia | Analytical testing | 3027666582 |
| Daewoong Pharmaceutical Co.,Ltd. | Chungcheongbuk-do 28162South Korea | Analytical testing, Labelling, Finished drug manufacture, Packaging | 3013514300 |
| Daewoong Bio Inc. | Gyeonggi-do 18608South Korea | Analytical testing, Active ingredient (API) manufacture | 3011083160 |
| Daewoong Pharmaceutical Co. Ltd. | Gyeonggi-do 18623South Korea | Analytical testing, Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging | 3012333115 |
Catalogue
Marketed products
1Showing 1 of 1.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | Ursodiol (Process IV) | POWDER | BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.